Phase 3 EU trial protocols flag potential liver safety risks for Bristol Myers Squibb’s admilparant in pulmonary fibrosis—see what it means for BMY.
On5, Bristol-Myers Squibb Company (NYSE:BMY) announced milestone results from its Phase 3 EXCALIBER-RRMM trial evaluating ...
Merck now has global rights to a SciBrunch Therapeutics drug candidate designed to block mutated versions of the ...
EVs, renewables, smart grids, 5G and data centers are accelerating SiC/GaN adoption, while local production offers opportunities to ease substrate shortages.Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- ...
In late 2026, Pfizer’s 5.99% yield outperforms 10-year Treasuries but lacks earnings coverage, raising sustainability concerns. - Analysts urge focus on dividend coverage over rate risks, as ...
Anvi Palav founded BioMedizone at 15 to bring biomedical research access to students in underserved communities.
- Bristol-Myers Squibb BMY-- (BMY) shares rose 0.57% on Sept 24, 2026, with $0.91B turnover—the highest daily trading volume ...
AI is reshaping clinical trials through smarter recruitment, predictive analytics, automation and digital twins, with strong opportunities in oncology, personalized medicine and Asia-Pacific.Dublin, ...
The Global Nanomedicine Market was valued at USD 207.91 Billion in 2025 and is projected to expand at a 12.1% CAGR from 2025 ...
Fresh off a career-best NASCAR O’Reilly Auto Parts Series finish last weekend at Bristol (Tenn.) Motor Speedway, Leander, ...
After an uncharacteristic postseason opener at Bristol Motor Speedway, Chase drivers in the NASCAR CRAFTSMAN Truck Series are ...
In just under two weeks, Bristol Motor Speedway will go from NASCAR tires burning rubber to exotic cars filling Entrance One. Car fans are fueled with joy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results